|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.430 USD | -2.18% |
|
+5.48% | -22.32% |
| 06-17 | Ocular Therapeutix, Inc. - Analyst/Investor Day | |
| 06-17 | Ocular Therapeutix Says Axpaxli New Drug Application Submission to US FDA Planned for Q4 | MT |
| Market Cap | 2.06B 1.8B 1.67B 1.56B 2.93B 195B 2.95B 19.78B 7.67B 95.9B 7.75B 7.58B 333B | P/E 2026 * |
-5.89x | P/E 2027 * | -6.73x |
|---|---|---|---|---|---|
| Enterprise Value | 1.7B 1.48B 1.37B 1.29B 2.41B 161B 2.43B 16.3B 6.32B 79.04B 6.39B 6.25B 274B | EV / Sales 2026 * |
32.8x | EV / Sales 2027 * | 16.8x |
| Free-Float |
99.06% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ocular Therapeutix, Inc.
| 1 day | -2.18% | ||
| 1 week | +5.48% | ||
| Current month | +4.66% | ||
| 1 month | +18.02% | ||
| 3 months | +14.03% | ||
| 6 months | -24.92% | ||
| Current year | -22.32% |
| 1 week | 8.62 |  | 10.39 |
| 1 month | 7.86 | | 10.39 |
| Current year | 6.23 | | 13.03 |
| 1 year | 6.23 | | 16.44 |
| 3 years | 2 | | 16.44 |
| 5 years | 2 | | 16.44 |
| 10 years | 2 | | 24.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pravin Dugel
CEO | Chief Executive Officer | 62 | 2024-04-14 |
Jason Robins
DFI | Director of Finance/CFO | 50 | 2026-01-19 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 49 | 2024-05-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Warden
CHM | Chairman | 57 | 2019-06-30 |
| Director/Board Member | 78 | 2012-11-04 | |
Leslie Williams
BRD | Director/Board Member | 66 | 2019-03-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-15 | Don | Chief Executive Officer | -100,184 | 0.0473% | ||
| 06-09 | Free | Director | 58,000 | 0.0274% | ||
| 06-09 | Free | Director | 58,000 | 0.0274% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.18% | +5.48% | +13.21% | +96.05% | 2.06B | |
| -1.21% | -3.04% | +39.94% | +145.38% | 980B | |
| -2.48% | -5.18% | +51.52% | +39.07% | 550B | |
| -2.14% | -4.94% | +16.71% | +56.15% | 382B | |
| +0.25% | -3.09% | +23.00% | +15.81% | 316B | |
| +0.61% | -1.69% | +25.42% | +13.64% | 272B | |
| +0.22% | -3.10% | +24.25% | +30.21% | 268B | |
| +4.59% | +1.98% | -40.02% | -45.89% | 199B | |
| -1.19% | -4.95% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.46% | +14.59% | +56.94% | 154B | |
| Average | -0.49% | -1.88% | +18.52% | +45.43% | 330.44B | |
| Weighted average by Cap. | -0.78% | -3.67% | +27.79% | +63.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 51.91M 45.26M 41.92M 39.24M 73.59M 4.9B 74.04M 497M 193M 2.41B 195M 191M 8.37B | 122M 106M 98.12M 91.86M 172M 11.47B 173M 1.16B 451M 5.64B 456M 446M 19.6B |
| Net income | -362M -315M -292M -273M -513M -34.11B -516M -3.46B -1.34B -16.79B -1.36B -1.33B -58.3B | -329M -287M -266M -249M -466M -31.04B -469M -3.15B -1.22B -15.28B -1.23B -1.21B -53.06B |
| Net Debt | -363M -316M -293M -274M -515M -34.25B -518M -3.48B -1.35B -16.86B -1.36B -1.33B -58.54B | -18M -15.69M -14.54M -13.61M -25.52M -1.7B -25.67M -172M -66.83M -836M -67.57M -66.12M -2.9B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 9.430 $ | -2.18% | 6,114,283 |
| 26-06-17 | 9.640 $ | +7.83% | 7,403,976 |
| 26-06-16 | 8.940 $ | -0.56% | 2,329,712 |
| 26-06-15 | 8.990 $ | +0.56% | 2,467,340 |
| 26-06-12 | 8.940 $ | +2.76% | 2,696,811 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCUL Stock
Select your edition
All financial news and data tailored to specific country editions
